SCHEMBL4882564

SCHEMBL4882564

O=C1C=CC(=O)N1CCON1C(=O)CCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 7/20 0.53
FAAH O00519 3/20 0.45
ALOX12 P18054 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 2/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSP90AA1 P07900 1/20 0.43
TLR9 Q9NR96 1/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
XBP1 P17861 1/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
GPR35 Q9HC97 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29270039 0.90 MGLL (0.67) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL28704923 0.89 MGLL (0.52) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL841624 0.87 MGLL (0.55) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL946089 0.86 MGLL (0.57) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL594145 0.86 MGLL (0.57) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL14868175 0.84 MGLL (0.61) MGLLFAAHSMN1; SMN2LMNAALDH1A1
SCHEMBL18522835 0.82 ALOX12 (0.41) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL19718345 0.81 MGLL (0.50) MGLLFAAHALOX12SMN1; SMN2LMNA
SCHEMBL13062545 0.77 MGLL (0.77) MGLLFAAHSMN1; SMN2LMNAALDH1A1
SCHEMBL12966013 0.77 MGLL (0.77) MGLLFAAHSMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020219287-A1 CAMPTOTHECIN DERIVATIVES IMMUNOGEN, INC. (US) 2020-10-29 WO disclosed
US-20160187324-A1 Antibody Conjugates VENTANA MED SYST INC (US) 2016-06-30 US disclosed
US-20080020483-A1 Fluorescence Detecting Method FUJIFILM CORPORATION (JP) 2008-01-24 US disclosed
EP-1775575-A1 FLUORESCENCE DETECTING METHOD FUJIFILM Corporation (JP) 2007-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160187324-A1 Antibody Conjugates BCR, CD2BP2, EPCAM MGLL 3100/4885FAAH 3105/4885ALOX12 1444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.